<--- Back to Details
First PageDocument Content
Blood / Coagulation system / Anatomy / Haemophilia / Peripheral membrane proteins / CSL Behring / Recombinant proteins / CSL Limited / Coagulation / Factor VII / Factor IX / Haemophilia C
Date: 2013-11-18 05:52:29
Blood
Coagulation system
Anatomy
Haemophilia
Peripheral membrane proteins
CSL Behring
Recombinant proteins
CSL Limited
Coagulation
Factor VII
Factor IX
Haemophilia C

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

Add to Reading List

Source URL: www.cslbehring.at

Download Document from Source Website

File Size: 58,99 KB

Share Document on Facebook

Similar Documents

News Releases  Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1qHpD - View Document

News Releases  Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1q38M - View Document

News Releases  Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1pMmB - View Document

13307 FT Factor VII plasma deficient

13307 FT Factor VII plasma deficient

DocID: 1mVEV - View Document

UPDATE: Baxalta’s BAX 855 Pivotal Data Published in Blood Shows  Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A •

UPDATE: Baxalta’s BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A •

DocID: 1kAcN - View Document